Innovent Biologics, Inc. (01801.HK) and Spero Therapeutics, Inc. today announced an exclusive license agreement for IBI355 (Spero R&D code: SP001), a third-generation Fc-silent anti-CD40L antibody.
Still booting from a hard drive? Storage prices may be rising, but these budget-minded solid-state drives will give your poky ...
Computer-Aided Aptamer Modeling and Optimization (CAAMO) enables structure-guided RNA aptamer affinity maturation, producing a SARS-CoV-2 RBD (receptor binding domain) binder that rivals neutralizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results